| Symbol | DXCM |
|---|---|
| Name | DEXCOM INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 6340 SEQUENCE DRIVE, SAN DIEGO, CA 92121 |
| Telephone | 8582000200 |
| Fax | — |
| — | |
| Website | https://www.dexcom.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001093557 |
| Description | DexCom Inc designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver. Additional info from NASDAQ: |
2026-04-29 19:25
New Form SCHEDULE 13G - DEXCOM INC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100119-26-000462 <b>Size:</b> 7 KB
Read more
2026-04-29 13:52
New Form SCHEDULE 13G - DEXCOM INC <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100121-26-000290 <b>Size:</b> 7 KB
Read more
2026-04-16 23:27
Brown Michael Jon 🔴 sold 1.7K shares of DEXCOM INC (DXCM) at $63.04 Transaction Date: Apr 15, 2026 | Filing ID: 000065
Read more
2026-04-15 17:14
New Form DEFA14A - DEXCOM INC <b>Filed:</b> 2026-04-15 <b>AccNo:</b> 0001093557-26-000062 <b>Size:</b> 5 MB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07221812 | Continuous Glucose Monitors (CGMs) and Readmission Rates | Na | Diabetes (DM) | Not_Yet_Recruiting | 2026-06-18 | 2028-06-17 | ClinicalTrials.gov |
| NCT07087340 | Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery S… | Na | Type-1-Diabetes | Recruiting | 2026-01-21 | 2026-04-30 | ClinicalTrials.gov |
| NCT07356986 | Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal … | — | Gestational Diabetes | Not_Yet_Recruiting | 2026-01-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT07212790 | REAL-Fam Feasibility Study for Youth Diabetes Management | Na | Type 1 Diabetes | Recruiting | 2025-12-15 | 2026-06-01 | ClinicalTrials.gov |
| NCT07520929 | Acute Sauna Session and Glucose Control | Na | Obesity & Overweight | Recruiting | 2025-12-01 | 2027-04-15 | ClinicalTrials.gov |
| NCT06490874 | Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT | — | Gestational Diabetes Mellitus | Withdrawn | 2025-09-01 | 2030-12-01 | ClinicalTrials.gov |
| NCT07054125 | Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Managem… | — | Type 2 Diabetes Mellitus - Poor Control | Recruiting | 2025-08-01 | 2028-08-01 | ClinicalTrials.gov |
| NCT06184373 | Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot | — | Gestational Diabetes | Recruiting | 2025-06-06 | 2027-05-30 | ClinicalTrials.gov |
| NCT06957028 | CGM for the Early Detection and Management of Hyperglycemia in Pregnancy | Na | Gestational Diabetes Mellitus in Pregnancy | Recruiting | 2025-05-27 | 2027-11-27 | ClinicalTrials.gov |
| NCT06752928 | A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose… | Na | Type 1 Diabetes | Recruiting | 2025-05-12 | 2026-10-01 | ClinicalTrials.gov |
| NCT06939413 | Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monito… | Na | Type 2 Diabetes Mellitus (T2DM) | Recruiting | 2025-03-18 | 2026-10-01 | ClinicalTrials.gov |
| NCT06507722 | Night Owl Metabolism | Na | PreDiabetes | Recruiting | 2025-02-25 | 2030-01-31 | ClinicalTrials.gov |
| NCT06841796 | The YMCA Healthy Lifestyle Program for Prediabetes | Na | PreDiabetes | Recruiting | 2025-02-17 | 2026-10-01 | ClinicalTrials.gov |
| NCT06805786 | Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose… | — | Type 2 Diabetes | Recruiting | 2025-02-11 | 2026-07-01 | ClinicalTrials.gov |
| NCT06728059 | Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Co… | Na | Type 1 Diabetes | Recruiting | 2025-02-05 | 2025-07-31 | ClinicalTrials.gov |
| NCT06645873 | Exploration of Continuous Glucose Monitoring on the Intensive Care Unit | Na | Hypoglycemia, Hyperglycemia | Completed | 2024-12-17 | 2025-09-30 | ClinicalTrials.gov |
| NCT06338748 | Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardia… | Na | Continuous Glucose Monitoring | Completed | 2024-11-02 | 2025-12-31 | ClinicalTrials.gov |
| NCT06217302 | Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes a… | Phase3 | Diabetic Nephropathies | Recruiting | 2024-10-31 | 2029-05-01 | ClinicalTrials.gov |
| NCT05662462 | Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 D… | Na | Pre-Gestational Diabetes | Recruiting | 2024-07-11 | 2029-03-01 | ClinicalTrials.gov |
| NCT06483945 | Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry… | — | Diabetes | Recruiting | 2024-02-28 | 2028-06-30 | ClinicalTrials.gov |
| NCT06057805 | The PPCGMS Intervention After GDM Trial | Na | Postpartum Gestational Diabetes Mellitus | Terminated | 2024-02-06 | 2024-10-16 | ClinicalTrials.gov |
| NCT06962735 | Real-world Effect of Switching From Intermittently-scanned to Real-time Continu… | — | Diabetes Mellitus | Completed | 2024-01-25 | 2024-08-29 | ClinicalTrials.gov |
| NCT06050265 | Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Synd… | Na | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | Active_Not_Recruiting | 2023-11-29 | 2026-12-01 | ClinicalTrials.gov |
| NCT06545227 | Early Versus Late Monitoring Among Pregnant Women With a History of Gestational… | — | Pregnancy Complications | Recruiting | 2023-11-20 | 2026-12-31 | ClinicalTrials.gov |
| NCT05766735 | Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A P… | Na | Type 2 Diabetes | Recruiting | 2023-08-08 | 2027-05-31 | ClinicalTrials.gov |
| NCT05059860 | Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes | — | Type 1 Diabetes Mellitus | Completed | 2023-06-09 | 2025-05-23 | ClinicalTrials.gov |
| NCT05663606 | Happy Bob App in 9-13 Year-old Children | Na | Type1diabetes | Unknown | 2023-06-01 | 2024-09-01 | ClinicalTrials.gov |
| NCT06363929 | Continuous Glucose Monitoring in Neonatal Hyperinsulinism | — | Hyperinsulinism | Terminated | 2023-06-01 | 2025-09-22 | ClinicalTrials.gov |
| NCT05442853 | Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients | Na | Hyperglycemia | Completed | 2023-04-01 | 2024-08-01 | ClinicalTrials.gov |
| NCT05734313 | Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for An… | Na | Diabetes | Recruiting | 2023-03-31 | 2027-12-01 | ClinicalTrials.gov |
| NCT05430204 | Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy | Na | Gestational Diabetes | Completed | 2023-03-07 | 2024-09-16 | ClinicalTrials.gov |
| NCT05714761 | Postpartum Continuous Glucose Monitoring (CGM) Study | Na | Gestational Diabetes | Completed | 2023-02-16 | 2024-03-08 | ClinicalTrials.gov |
| NCT05746286 | Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dy… | Na | Dysglycemia | Completed | 2023-02-01 | 2024-06-24 | ClinicalTrials.gov |
| NCT06275971 | Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Pat… | Na | Cardiac Disease | Unknown | 2022-11-24 | 2024-08-31 | ClinicalTrials.gov |
| NCT05394844 | Diabetes Education With Real-time Continuous Glucose Monitoring | Na | Diabetes Type 2 | Completed | 2022-11-11 | 2024-11-30 | ClinicalTrials.gov |
| NCT05666479 | CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery | — | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2022-09-09 | 2024-09-01 | ClinicalTrials.gov |
| NCT04261738 | Effects of HBO on Glucose in Patients With DM | Na | Diabetes Mellitus, Type 2 | Suspended | 2022-09-02 | 2026-12-01 | ClinicalTrials.gov |
| NCT05370612 | AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy | Na | Type2Diabetes | Completed | 2022-08-08 | 2024-10-06 | ClinicalTrials.gov |
| NCT05000021 | Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults W… | Na | Type 1 Diabetes | Recruiting | 2022-06-27 | 2026-06-01 | ClinicalTrials.gov |
| NCT05439928 | Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoaci… | Na | Diabetic Ketoacidosis | Completed | 2022-06-07 | 2023-03-31 | ClinicalTrials.gov |
| NCT05478070 | Continuous Glucose Monitoring for Personal Protective Equipment Evaluation | Na | Diabetes Mellitus (DM) | Unknown | 2022-05-15 | 2023-05-01 | ClinicalTrials.gov |
| NCT05006040 | HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALL | Early_Phase1 | High Risk Acute Lymphoblastic Leukemia | Terminated | 2022-05-12 | 2023-08-01 | ClinicalTrials.gov |
| NCT05135676 | Time in Glucose Hospital Target | Na | Diabetes Mellitus, Type 2 | Completed | 2022-05-10 | 2024-03-01 | ClinicalTrials.gov |
| NCT05360056 | Continuous Glucose Monitoring Following Hospital Discharge | Na | Type 2 Diabetes | Active_Not_Recruiting | 2022-04-26 | 2026-07-01 | ClinicalTrials.gov |
| NCT05299177 | Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using… | Na | Type 1 Diabetes | Terminated | 2022-04-01 | 2025-08-31 | ClinicalTrials.gov |
| NCT05233592 | Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes | — | Type 1 Diabetes | Completed | 2022-03-08 | 2023-04-04 | ClinicalTrials.gov |
| NCT05607576 | Dexcom G6 for Total Pancreatectomy With Islet Autotransplantation (TPIAT) Patie… | Na | Diabetes | Completed | 2022-03-01 | 2024-05-01 | ClinicalTrials.gov |
| NCT05431686 | Group Visits for High Risk Type 1 Diabetes (T1D) | Na | Type 1 Diabetes | Completed | 2022-02-16 | 2025-07-01 | ClinicalTrials.gov |
| NCT05523362 | Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring… | Na | Type 2 Diabetes | Completed | 2022-01-15 | 2023-11-30 | ClinicalTrials.gov |
| NCT05537480 | Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women W… | Na | Pregnancy Complications | Unknown | 2022-01-14 | 2024-11-01 | ClinicalTrials.gov |
| NCT05255783 | The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients | Na | Blood Glucose | Completed | 2021-11-19 | 2023-05-15 | ClinicalTrials.gov |
| NCT05168488 | Repeatability of Blood Glucose Responses to Resistance Exercise in Type 1 Diabe… | Na | Type 1 Diabetes | Completed | 2021-11-16 | 2023-12-16 | ClinicalTrials.gov |
| NCT04540536 | Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitorin… | Na | Diabetes Mellitus, Type 1 | Completed | 2021-11-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT05067075 | The CGMS in GDM Labor and Delivery Study | Na | Gestational Diabetes Mellitus in Pregnancy | Completed | 2021-11-01 | 2023-04-18 | ClinicalTrials.gov |
| NCT05000840 | Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… | — | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2021-10-20 | 2025-03-31 | ClinicalTrials.gov |
| NCT04948112 | Effectiveness of CGMS Vs. Self-monitoring Blood Glucose (SMBG) in Woman with Ge… | Na | Gestational Diabetes Mellitus in Pregnancy | Completed | 2021-10-01 | 2024-06-30 | ClinicalTrials.gov |
| NCT04386005 | Continuous Glucose Monitoring in At-Risk Newborns | Na | Neonatal Hypoglycemia | Recruiting | 2021-08-09 | 2026-06-01 | ClinicalTrials.gov |
| NCT04905628 | Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnan… | — | Diabetes Mellitus | Unknown | 2021-07-08 | 2022-04-15 | ClinicalTrials.gov |
| NCT04783441 | Use of CGM in Kidney Transplant Recipients | Na | Kidney Transplant; Complications | Recruiting | 2021-06-29 | 2026-12-31 | ClinicalTrials.gov |
| NCT04879693 | Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System … | Na | Patients Needing Glucose Control | Unknown | 2021-06-01 | 2021-12-01 | ClinicalTrials.gov |
| NCT04569240 | Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardia… | Na | Surgery--Complications | Completed | 2021-05-01 | 2024-07-01 | ClinicalTrials.gov |
| NCT04818242 | Dexcom Continuous Glucose Monitoring in Long-term Care | Na | Diabetes | Completed | 2021-04-19 | 2022-10-21 | ClinicalTrials.gov |
| NCT04803357 | A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gest… | Na | Gestational Diabetes | Completed | 2021-04-10 | 2025-01-15 | ClinicalTrials.gov |
| NCT04189510 | Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insuli… | Na | Type 1 Diabetes | Withdrawn | 2021-04-01 | 2021-12-31 | ClinicalTrials.gov |
| NCT04794478 | Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Mon… | Na | Diabetes Mellitus | Completed | 2021-02-19 | 2021-10-31 | ClinicalTrials.gov |
| NCT04605497 | Time-in-range Using Continuous Glucose Monitoring Management of Gestational Dia… | Na | Gestational Diabetes | Completed | 2021-02-11 | 2023-12-31 | ClinicalTrials.gov |
| NCT04840446 | Evaluation of Modified Adhesives With Dexcom G6 Sensor | — | Diabetes | Completed | 2021-02-08 | 2021-03-19 | ClinicalTrials.gov |
| NCT04721145 | CGM Use in Poorly Controlled Youth With Type 1 Diabetes | Na | Type 1 Diabetes | Completed | 2021-01-25 | 2022-06-28 | ClinicalTrials.gov |
| NCT04665999 | Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With… | — | Type 1 Diabetes Mellitus | Completed | 2021-01-15 | 2022-03-10 | ClinicalTrials.gov |
| NCT04510506 | Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation | Na | Type 1 Diabetes | Completed | 2020-11-19 | 2025-10-24 | ClinicalTrials.gov |
| NCT04352907 | Accuracy of CGM in the ICU, Compared to Standard of Care | — | Diabetes | Unknown | 2020-11-06 | 2022-09-01 | ClinicalTrials.gov |
| NCT04645641 | Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CG… | Na | Diabetes Mellitus | Unknown | 2020-10-12 | 2020-12-01 | ClinicalTrials.gov |
| NCT04753099 | Telehealth Family Coaching With Type 1 Diabetes | Na | Diabetes Mellitus, Type 1 | Completed | 2020-10-09 | 2021-05-05 | ClinicalTrials.gov |
| NCT04585139 | Assessing Non-adjunctive CGM Safety at Home and in New Markets | Na | Diabetes Mellitus | Completed | 2020-10-06 | 2022-02-07 | ClinicalTrials.gov |
| NCT04458649 | Continuous Glucose Monitoring in Infants | — | Neonatal Hypoglycemia | Recruiting | 2020-10-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT04016662 | Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D) | Phase4 | Type 1 Diabetes Mellitus | Completed | 2020-09-28 | 2024-01-05 | ClinicalTrials.gov |
| NCT04039763 | RT-CGM in Young Adults at Risk of DKA | Na | Diabetes Mellitus | Recruiting | 2020-09-03 | 2022-06-30 | ClinicalTrials.gov |
| NCT03981328 | Real-time Continuous Glucose Monitoring for Reduced Adverse Complications and E… | Na | Cgm | Completed | 2020-08-24 | 2025-02-28 | ClinicalTrials.gov |
| NCT05504785 | DexCom Hospital Study-CGM Directed Insulin Delivery | Na | Type 2 Diabetes | Terminated | 2020-08-01 | 2022-08-01 | ClinicalTrials.gov |
| NCT04503239 | Prediabetes and Type 2 Diabetes Data Collection Study | — | Diabetes Mellitus, Type 2 | Unknown | 2020-07-22 | 2022-02-27 | ClinicalTrials.gov |
| NCT04233034 | Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onse… | Phase3 | Type1 Diabetes | Completed | 2020-07-09 | 2022-09-30 | ClinicalTrials.gov |
| NCT04313803 | CGM in Utah Valley | — | Diabetes Mellitus | Unknown | 2020-04-01 | 2021-04-30 | ClinicalTrials.gov |
| NCT04217161 | Dexcom G6 Continuous Glucose Monitoring in Hemodialysis | Na | Diabetes | Unknown | 2020-03-01 | 2023-12-21 | ClinicalTrials.gov |
| NCT04269655 | Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM) | Na | Diabetes Mellitus, Type 2 | Terminated | 2020-02-25 | 2020-03-17 | ClinicalTrials.gov |
| NCT04094064 | Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With … | Na | Diabetes | Completed | 2020-02-19 | 2021-09-29 | ClinicalTrials.gov |
| NCT04225455 | The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes | — | Insulin Dependent Diabetes | Active_Not_Recruiting | 2019-12-05 | 2025-12-30 | ClinicalTrials.gov |
| NCT04084171 | Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 | Na | Type 1 Diabetes | Completed | 2019-09-26 | 2019-10-23 | ClinicalTrials.gov |
| NCT03963219 | Clinical Assessment of a Novel Advanced Bolus Calculator for Type 1 Diabetes 5 | Na | Type 1 Diabetes Mellitus | Unknown | 2019-08-22 | 2021-06-30 | ClinicalTrials.gov |
| NCT05081817 | Accuracy Comparison of Two CGMs in Hospitalized Patients | — | Type 1 Diabetes | Completed | 2019-08-01 | 2022-12-31 | ClinicalTrials.gov |
| NCT03935191 | Performance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Preg… | — | Diabetes | Unknown | 2019-05-01 | 2019-05-31 | ClinicalTrials.gov |
| NCT04529824 | Glucose Risk Assessment in Employer Populations | — | Diabetes | Completed | 2019-04-01 | 2021-08-01 | ClinicalTrials.gov |
| NCT03353415 | Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After G… | Na | Hypoglycemia, Reactive | Completed | 2019-02-07 | 2023-04-12 | ClinicalTrials.gov |
| NCT03772600 | Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabet… | Na | Type 1 Diabetes Mellitus | Completed | 2019-01-29 | 2022-11-30 | ClinicalTrials.gov |
| NCT03805412 | Continuous Glucose Monitoring in Diabetes and Prediabetes | Na | Diabetes Mellitus, Type 2 | Completed | 2019-01-10 | 2020-07-03 | ClinicalTrials.gov |
| NCT03709108 | Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in T… | Na | Type 1 Diabetes Mellitus | Completed | 2018-11-19 | 2019-03-31 | ClinicalTrials.gov |
| NCT03674281 | The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System | Na | Type 1 Diabetes Mellitus | Completed | 2018-09-24 | 2019-11-21 | ClinicalTrials.gov |
| NCT03620357 | Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) | Na | Diabetes Mellitus, Type 2 | Completed | 2018-09-05 | 2020-11-04 | ClinicalTrials.gov |
| NCT02572856 | Continuous Glucose Monitoring During and After Surgery | Na | Diabetes | Completed | 2018-08-01 | 2021-11-16 | ClinicalTrials.gov |
| NCT03566693 | Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE) | Na | Diabetes Mellitus, Type 2 | Completed | 2018-07-30 | 2021-01-04 | ClinicalTrials.gov |
| NCT03207893 | Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for A… | Na | Diabetes Mellitus, Type 2 | Completed | 2018-07-19 | 2020-01-23 | ClinicalTrials.gov |
| NCT03443713 | Evaluation of Physician-based Decision Support | Na | Type 1 Diabetes Mellitus | Completed | 2018-07-18 | 2019-05-08 | ClinicalTrials.gov |
| NCT03445377 | Comparison of Real-tiMe ContInuous gLucosE moNitoriNg With Self-monitorIng of B… | Na | Diabetes Mellitus, Type 1 | Completed | 2018-07-16 | 2020-06-28 | ClinicalTrials.gov |
| NCT03427931 | CGM Use in Islet Transplant Recipients | Na | Islet Transplantation | Completed | 2018-02-01 | 2019-07-11 | ClinicalTrials.gov |
| NCT03394352 | Exercise Activity-Based Bolus Decisions in Type 1 Diabetes | Na | Type 1 Diabetes Mellitus | Completed | 2018-01-17 | 2018-05-11 | ClinicalTrials.gov |
| NCT02985866 | The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 | Na | Type1 Diabetes Mellitus | Completed | 2017-10-27 | 2018-09-04 | ClinicalTrials.gov |
| NCT03340831 | Continuous Monitoring and Control of Hypoglycemia | — | Diabetes | Unknown | 2017-10-20 | 2023-12-30 | ClinicalTrials.gov |
| NCT03087877 | Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Int… | Na | Diabetes Mellitus | Completed | 2017-02-03 | 2017-03-04 | ClinicalTrials.gov |
| NCT02904512 | Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring … | Na | Diabetes Mellitus | Completed | 2016-10-01 | 2017-12-22 | ClinicalTrials.gov |
| NCT02843503 | Factors in Accuracy Studies Influencing Measured CGM Performance. | Na | Diabetes Mellitus, Type 1 | Completed | 2016-07-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02750267 | Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform | Na | Diabetes Mellitus, Type 1 | Completed | 2016-05-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02880267 | Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System | Na | Diabetes Mellitus | Completed | 2016-05-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02671968 | Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabet… | Na | Diabetes | Completed | 2016-02-01 | 2017-10-24 | ClinicalTrials.gov |
| NCT02604524 | Reducing Risks and Improving Glucose Control During Extended Exercise in Youth … | Na | Type 1 Diabetes Mellitus | Completed | 2016-01-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02696252 | G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor App… | — | Diabetes Mellitus | Completed | 2016-01-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02556554 | Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy | Na | Diabetes Mellitus, Type I | Completed | 2015-08-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT02465411 | Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin I… | Na | Diabetes Mellitus Type 1 | Completed | 2015-06-01 | 2017-05-31 | ClinicalTrials.gov |
| NCT02282397 | Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes | Na | Diabetes Mellitus | Completed | 2014-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02092051 | CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections | Na | Diabetes Mellitus, Type 1 | Completed | 2014-01-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01939834 | Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 … | Na | Type 1 Diabetes Mellitus | Terminated | 2013-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT02087995 | Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm | Na | Diabetes Mellitus | Completed | 2013-12-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01945060 | Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator | Na | Type 1 Diabetes Mellitus | Completed | 2013-09-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01839370 | Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 … | Na | Diabetes Mellitus, Type 1 | Completed | 2013-07-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01835964 | Biobehavioral Mechanisms of Glucose Variability | Na | Diabetes Mellitus, Type 1 | Completed | 2013-04-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT02363907 | Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 C… | — | Diabetes Mellitus | Completed | 2012-09-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01667185 | Effectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System… | — | Pediatric Subjects With Diabetes Mellitus | Completed | 2012-07-01 | — | ClinicalTrials.gov |
| NCT01627210 | Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring W… | — | Diabetes Mellitus | Completed | 2012-05-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01741467 | The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diab… | Na | Pre-diabetes | Completed | 2012-05-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01680653 | Testing State of the Art Remote Glucose Monitoring at Diabetes Camp | Na | Type 1 Diabetes | Completed | 2012-05-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01627184 | Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus | — | Diabetes Mellitus | Completed | 2012-05-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01582139 | Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… | Na | Type 1 Diabetes Mellitus | Completed | 2012-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01514292 | Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring … | Na | Diabetes | Completed | 2011-12-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01514305 | Observational Study to Evaluate the Effectiveness and Safety Study of the Dexco… | — | Diabetes | Completed | 2011-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01111370 | Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring … | Na | Diabetes Mellitus | Completed | 2010-02-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT01390259 | Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… | Na | Type 1 Diabetes Mellitus | Completed | 2010-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00906490 | Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult El… | — | Blood Glucose | Completed | 2009-06-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00925080 | Pivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic Setting | — | Diabetes | Completed | 2009-06-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT01104142 | Efficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mell… | — | Type 1 Diabetes Mellitus | Completed | 2009-04-01 | — | ClinicalTrials.gov |
| NCT00850135 | Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With… | Phase1 | Diabetes, Gestational | Completed | 2009-02-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00939289 | Concurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type… | — | Type 1 Diabetes Mellitus | Completed | 2008-07-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00722241 | Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous… | — | Diabetes Mellitus, Type 1 | Completed | 2008-05-01 | 2008-07-01 | ClinicalTrials.gov |
Total clinical trials: 140
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| CGM | Other | Approved | Diabetes Mellitus | COMPLETED | NCT02880267 |
| CLC | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03674281 |
| SAP | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03674281 |
| Routine Care | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03207893 |
| GEM lifestyle modification & continuous glucose monitoring | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03207893 |
| Blood glucose meter | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03566693 |
| Dexcom G6 CGM System | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03566693 |
| Self monitoring of blood glucose | Other | Approved | Diabetes Mellitus | RECRUITING | NCT04039763 |
| Dexcom G6 | Other | Approved | Diabetes Mellitus | RECRUITING | NCT04039763 |
| Hyperbaric Oxygen | Other | Approved | Diabetes Mellitus, Type 2 | SUSPENDED | NCT04261738 |
| Tandem Control IQ Hybrid Closed Loop Insulin Delivery System | Other | Preclinical | Type 1 Diabetes Mellitus | COMPLETED | NCT05059860 |
| CGM | Other | Preclinical | Type 1 Diabetes Mellitus | COMPLETED | NCT01104142 |
| Closed Loop with Pramlintide | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01839370 |
| Heart rate informed SSM+HMM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01582139 |
| Closed-Loop | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01390259 |
| Open-Loop | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01390259 |
| Dexcom G4 CGM System | Other | Preclinical | Diabetes Mellitus | COMPLETED | NCT01627184 |
| Continuous Glucose Monitoring of glucose levels (Dexcom) | Other | Approved | Diabetes | COMPLETED | NCT01514292 |
| RT-CGM | Other | Approved | Pre-diabetes | COMPLETED | NCT01741467 |
| Continuous glucose monitoring with DexCom G4 platina | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02092051 |
| Capillary reference (SMBG) | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| Venous reference measurement (YSI) | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| Arterialized-venous reference (YSI) | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| DexCom™ G4 Continuous Glucose Monitoring System | Other | Approved | Diabetes Mellitus | COMPLETED | NCT01111370 |
| Continuous Glucose Monitor | Other | Approved | Diabetes Mellitus | COMPLETED | NCT02282397 |
| Diabetes Assistant (DiAs) with Closed-Loop | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02750267 |
| Continuous Glucose Monitoring | Other | Approved | Diabetes Mellitus | COMPLETED | NCT02087995 |
| Dexcom G4 or later generation | Other | Approved | Diabetes Mellitus Type 1 | COMPLETED | NCT02465411 |
| Carbohydrates | Other | Approved | Type 1 Diabetes | COMPLETED | NCT01680653 |
| Remote monitoring | Other | Approved | Type 1 Diabetes | COMPLETED | NCT01680653 |
| Mini-glucagon | Other | Approved | Type 1 Diabetes | COMPLETED | NCT01680653 |
| Continuous Glucose Monitoring System | Other | Approved | Diabetes | COMPLETED | NCT02671968 |
| Continuous Glucose Monitoring System | Other | Approved | Diabetes | COMPLETED | NCT02671968 |
| Usual Diabetes Care | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03394352 |
| Activity on Board | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03394352 |
| Sensor Augmented Pump Therapy | Drug | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT02604524 |
| Closed-Loop Control | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT02604524 |
| Acetaminophen Challenge (G6 CGM) | Other | Approved | Diabetes Mellitus | COMPLETED | NCT03087877 |
| Dexcom CGM System | Other | Preclinical | Diabetes | UNKNOWN | NCT03935191 |
| CGM | Other | Preclinical | Diabetes Mellitus | UNKNOWN | NCT04313803 |
| Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03443713 |
| Dexcom G4 or G5 Platinum CGM system with Share | Other | Approved | Diabetes Mellitus, Type I | COMPLETED | NCT02556554 |
| Dexcom G4 or G5 Platinum CGM system | Other | Approved | Diabetes Mellitus, Type I | COMPLETED | NCT02556554 |
| Continuous Glucose Monitor (CGM) | Other | Approved | Islet Transplantation | COMPLETED | NCT03427931 |
| Standard Bolus Calculator | Other | Approved | Type 1 Diabetes Mellitus | UNKNOWN | NCT03963219 |
| ABC4D | Other | Approved | Type 1 Diabetes Mellitus | UNKNOWN | NCT03963219 |
| Continuous Glucose Monitoring System | Other | Approved | Diabetes Mellitus | UNKNOWN | NCT04645641 |
| Self-monitoring of blood glucose | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03445377 |
| Real-time continuous glucose monitoring | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03445377 |
| SMBG | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03620357 |
| CGM | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03620357 |
| Dexcom Continuous Glucose Monitoring System | Other | Preclinical | Diabetes | COMPLETED | NCT04840446 |
| Continuous Glucose Monitoring System | Other | Approved | Patients Needing Glucose Control | UNKNOWN | NCT04879693 |
| occupation-based coaching | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04753099 |
| Point of Care (POC) blood glucose | Other | Approved | Diabetes Mellitus | COMPLETED | NCT02904512 |
| Continuous glucose Monitoring (CGM) device and Point of Care (POC) blood glucose | Device | Approved | Diabetes Mellitus | COMPLETED | NCT02904512 |
| Continuous Glucose Monitoring (CGM) | Other | Preclinical | Diabetes | UNKNOWN | NCT03340831 |
| Multiple Daily Injections | Other | Approved | Type 1 Diabetes | WITHDRAWN | NCT04189510 |
| Artificial Pancreas | Other | Approved | Type 1 Diabetes | WITHDRAWN | NCT04189510 |
| Dexcom Continuous Glucose Monitoring System | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04794478 |
| Dexcom CGM System | Other | Preclinical | Diabetes Mellitus | UNKNOWN | NCT04905628 |
| Continuous Glucose Monitor | Other | Preclinical | Type 1 Diabetes Mellitus | COMPLETED | NCT04665999 |
| Continuous Glucose Sensor | Other | Preclinical | Diabetes | UNKNOWN | NCT04352907 |
| Dexcom G6 | Other | Approved | Diabetes Mellitus (DM) | UNKNOWN | NCT05478070 |
| Phase 1- Introduction to Dexcom G6 CGM | Other | Approved | Diabetes Mellitus | COMPLETED | NCT04585139 |
| DexCom G6 continuous glucose monitor | Other | Approved | Type 2 Diabetes | TERMINATED | NCT05504785 |
| Continuous glucose monitoring device | Device | Approved | Pregnancy Complications | UNKNOWN | NCT05537480 |
| Sensor Augmented Therapy | Drug | Approved | Type1 Diabetes Mellitus | COMPLETED | NCT02985866 |
| Artificial Pancreas | Other | Approved | Type1 Diabetes Mellitus | COMPLETED | NCT02985866 |
| Continuous Glucose Monitor | Other | Approved | Diabetes | COMPLETED | NCT04094064 |
| Dexcom G6 CGM | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03772600 |
| Dexcom G6 Continuous Glucose Monitor (CGM) System | Other | Preclinical | Diabetes | COMPLETED | NCT04529824 |
| DEXCOM G6 RT-CGM | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03805412 |
| Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04084171 |
| CGM | Other | Approved | Type1diabetes | UNKNOWN | NCT05663606 |
| Happy Bob | Other | Approved | Type1diabetes | UNKNOWN | NCT05663606 |
| CGM | Other | Preclinical | Type 1 Diabetes | COMPLETED | NCT05233592 |
| Cloud-Based Continuous Glucose Monitoring | Other | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04269655 |
| Dexcom G6 Continuous Glucose Monitor | Other | Approved | Diabetes | UNKNOWN | NCT04217161 |
| Glucose Variability Observation | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01835964 |
| Dexcom G6 Continuous Glucose Monitor | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04721145 |
| DiAs Control-to-Range System not informed for heart rate | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01945060 |
| heart rate Control to Range System (hrCTR) using DiAs Platform | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01945060 |
| Blinded CGM | Other | Approved | Gestational Diabetes Mellitus in Pregnancy | COMPLETED | NCT05067075 |
| Dexcom CGM unmasked | Other | Approved | Hypoglycemia, Reactive | COMPLETED | NCT03353415 |
| Dexcom CGM masked | Other | Approved | Hypoglycemia, Reactive | COMPLETED | NCT03353415 |
| Continuous Glucose Monitor (CGM) | Other | Approved | Diabetes | COMPLETED | NCT02572856 |
| POC Blood Glucose Test + Blinded CGM | Other | Approved | Diabetes | COMPLETED | NCT04818242 |
| Dexcom G6 CGM with GTS | Other | Approved | Diabetes | COMPLETED | NCT04818242 |
| Afternoon resistance exercise | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05168488 |
| Fasted morning resistance exercise | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05168488 |
| SMBG or venous/arterial blood glucose | Other | Approved | Cardiac Disease | UNKNOWN | NCT06275971 |
| Dexcom G6 | Other | Approved | Cardiac Disease | UNKNOWN | NCT06275971 |
| real-time CGM | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT05135676 |
| Blinded CGM | Other | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT05135676 |
| Dexcom G6 Pro Continuous Glucose Monitor (CGM) | Other | Preclinical | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05666479 |
| Hybrid Closed Loop System | Other | Phase EARLY_PHASE1 | High Risk Acute Lymphoblastic Leukemia | TERMINATED | NCT05006040 |
| Sensor-Augmented Pump Therapy (SAP) | Drug | Approved | Type 1 Diabetes Mellitus | TERMINATED | NCT01939834 |
| Overnight CLC | Other | Approved | Type 1 Diabetes Mellitus | TERMINATED | NCT01939834 |
| Self-Capillary Blood Glucose Monitoring (SCBG) | Other | Approved | Gestational Diabetes | COMPLETED | NCT04605497 |
| Continuous glucose monitoring (CGM) | Other | Approved | Gestational Diabetes | COMPLETED | NCT04605497 |
| Dexcom CGM G6/G6 Pro/G7 | Other | Preclinical | Diabetes | RECRUITING | NCT06483945 |
| Dexcom continuous glucose monitor | Other | Preclinical | Neonatal Hypoglycemia | RECRUITING | NCT04458649 |
| SI-Informed Bolus Calculator | Other | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03709108 |
| Dexcom continuous glucose monitor | Other | Approved | Type 2 Diabetes | COMPLETED | NCT05523362 |
| Maternal and neonatal outcome data collection for all women in the study | Other | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Collection of umbilical cord blood, placental samples and cord tissue in a subset of women (n=25) | Other | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Collection of urine, maternal blood at baseline and 28 weeks in a subset of women (n=25) | Other | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| continuous blood glucose monitoring in a subset of women (n=25) in the early monitoring group. | Other | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Blinded Dexcom G7 CGM | Other | Approved | Postpartum Gestational Diabetes Mellitus | TERMINATED | NCT06057805 |
| blinded continuous glucose monitor | Other | Approved | Gestational Diabetes Mellitus in Pregnancy | COMPLETED | NCT04948112 |
| real time continuous glucose monitor | Other | Approved | Gestational Diabetes Mellitus in Pregnancy | COMPLETED | NCT04948112 |
| subcutaneous continuous glucose sensor | Other | Approved | Blood Glucose | COMPLETED | NCT05255783 |
| placebo | Other | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| non-HCL | Other | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| verapamil 120mg tablet | Other | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| HCL | Other | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| Tandem t:slim X2 with HCL or PLGS | Other | Phase PHASE4 | Type 1 Diabetes Mellitus | COMPLETED | NCT04016662 |
| Real time continuous glucose monitor (Stelo) | Other | Approved | PreDiabetes | RECRUITING | NCT06841796 |
| Dexcom glucose sensor | Other | Approved | Gestational Diabetes | COMPLETED | NCT05714761 |
| Enrollment in existing SDRI diabetes education programs | Other | Preclinical | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05000840 |
| self-monitored blood glucose | Other | Approved | Cgm | COMPLETED | NCT03981328 |
| Dexcom G6 Continuous Glucose Monitoring System | Other | Approved | Cgm | COMPLETED | NCT03981328 |
| Point of care glucose monitoring | Other | Approved | Hyperglycemia | COMPLETED | NCT05442853 |
| Continuous glucose monitoring | Other | Approved | Hyperglycemia | COMPLETED | NCT05442853 |
| Continuous glucose monitor (CGM) | Other | Approved | Type 2 Diabetes Mellitus (T2DM) | RECRUITING | NCT06939413 |
| real-time continuous glucose monitor | Other | Preclinical | Type 2 Diabetes | RECRUITING | NCT06805786 |
| Uncovered CGM during radiologic procedures | Procedure | Approved | Diabetes | COMPLETED | NCT05607576 |
| real-time continuous glucose monitor | Other | Preclinical | Diabetes Mellitus | COMPLETED | NCT06962735 |
| DEXCOM G6 CGM | Other | Approved | Diabetic Ketoacidosis | COMPLETED | NCT05439928 |
| AIDANET+ BPS_RL→AIDANET | Other | Approved | Type 1 Diabetes | RECRUITING | NCT06728059 |
| Automated Insulin Delivery Adaptive NETwork (AIDANET) | Other | Approved | Type 1 Diabetes | RECRUITING | NCT06728059 |
| Provider dashboard | Other | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Care team coaching for medical and social needs (HUB) | Other | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Patient mHealth app linked to a provider dashboard | Other | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| DEXCOM G7 PRO Continuous Glucose Monitor | Other | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Timing of Standardized Meal | Other | Approved | PreDiabetes | RECRUITING | NCT06507722 |
| Timing of OGTT | Other | Approved | PreDiabetes | RECRUITING | NCT06507722 |
| Continuous glucose monitor | Other | Approved | Gestational Diabetes | COMPLETED | NCT04803357 |
| Education, lifestyle counseling, and peer support | Other | Preclinical | Type 2 Diabetes Mellitus - Poor Control | RECRUITING | NCT07054125 |
| Continuous Glucose Monitoring Device | Device | Approved | Neonatal Hypoglycemia | RECRUITING | NCT04386005 |
| InControl | Other | Approved | Type 1 Diabetes | TERMINATED | NCT05299177 |
| Dexcom Stelo real-time Continuous Glucose Monitor | Other | Preclinical | Gestational Diabetes | NOT_YET_RECRUITING | NCT07356986 |
| Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode | Other | Approved | Continuous Glucose Monitoring | COMPLETED | NCT06338748 |
| Dexcom G6 continuous glucose monitor | Other | Preclinical | Hyperinsulinism | TERMINATED | NCT06363929 |
| Continuous glucose monitoring (CGM) device | Device | Approved | Hypoglycemia, Hyperglycemia | COMPLETED | NCT06645873 |
| Capillary Blood glucose Testing (POC) | Other | Approved | Type 1 Diabetes | RECRUITING | NCT06752928 |
| Dexcom G7 rtCGM | Other | Approved | Type 1 Diabetes | RECRUITING | NCT06752928 |
| CGM device - Insulin group | Device | Preclinical | Gestational Diabetes Mellitus | WITHDRAWN | NCT06490874 |
| CGM device - Metformin group | Device | Preclinical | Gestational Diabetes Mellitus | WITHDRAWN | NCT06490874 |
| Continuous Glucose Monitoring (CGM) | Other | Approved | Diabetes | RECRUITING | NCT05734313 |
| Unified protocol for cognitive behavioral therapy (UP-CBT) | Drug | Approved | Diabetes | RECRUITING | NCT05734313 |
| Dexcom G6 continuous glucose monitor | Other | Approved | Surgery--Complications | COMPLETED | NCT04569240 |
| Glucose monitoring | Other | Preclinical | Insulin Dependent Diabetes | ACTIVE_NOT_RECRUITING | NCT04225455 |
| Dexcom G6 CGM | Other | Approved | Dysglycemia | COMPLETED | NCT05746286 |
| Dexcom G6 | Other | Approved | Diabetes Type 2 | COMPLETED | NCT05394844 |
| Group 2: CGM placement | Other | Approved | Gestational Diabetes | COMPLETED | NCT05430204 |
| Group 1: one-hour GCT | Other | Approved | Gestational Diabetes | COMPLETED | NCT05430204 |
| Artificial Pancreas (AP) | Other | Approved | Type 1 Diabetes | COMPLETED | NCT04510506 |
| SMA visits | Other | Approved | Type 1 Diabetes | COMPLETED | NCT05431686 |
| Usual Care Group | Other | Approved | Gestational Diabetes Mellitus in Pregnancy | RECRUITING | NCT06957028 |
| Diabetes Treatment | Drug | Approved | Gestational Diabetes Mellitus in Pregnancy | RECRUITING | NCT06957028 |
| Continuous Glucose Monitoring (CGM) | Other | Approved | Type 1 Diabetes | RECRUITING | NCT05000021 |
| Cognitive Behavioral Therapy for Diabetes Distress (CBT-DD) with Continuous Glucose Monitoring | Drug | Approved | Type 1 Diabetes | RECRUITING | NCT05000021 |
| Hemoglobin A1c | Other | Preclinical | Gestational Diabetes | RECRUITING | NCT06184373 |
| Oral Glucose Tolerance Test | Other | Preclinical | Gestational Diabetes | RECRUITING | NCT06184373 |
| Continuous glucose monitor | Other | Preclinical | Gestational Diabetes | RECRUITING | NCT06184373 |
| REAL-Fam Occupational Therapy Family Coaching | Drug | Approved | Type 1 Diabetes | RECRUITING | NCT07212790 |
| Dexcom G6 blinded sensor | Other | Approved | Kidney Transplant; Complications | RECRUITING | NCT04783441 |
| Dexcom G6 | Other | Approved | Kidney Transplant; Complications | RECRUITING | NCT04783441 |
| UBLoop System | Other | Approved | Type-1-Diabetes | RECRUITING | NCT07087340 |
| Secure texting | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04540536 |
| Continuous Glucose Monitoring | Other | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04540536 |
| DEXCOM Continuous Glucose Monitor (CGM) | Other | Approved | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | ACTIVE_NOT_RECRUITING | NCT06050265 |
| Placebo | Other | Phase PHASE3 | Diabetic Nephropathies | RECRUITING | NCT06217302 |
| Sotagliflozin | Other | Phase PHASE3 | Diabetic Nephropathies | RECRUITING | NCT06217302 |
| Participant Finger Stick Glucose Monitoring | Other | Approved | Type2Diabetes | COMPLETED | NCT05370612 |
| Dexcom G6 CGM | Other | Approved | Type2Diabetes | COMPLETED | NCT05370612 |
| Resting condition | Other | Approved | Obesity & Overweight | RECRUITING | NCT07520929 |
| Infrared sauna session | Other | Approved | Obesity & Overweight | RECRUITING | NCT07520929 |
| Routine Care (RC) | Other | Approved | Type 2 Diabetes | RECRUITING | NCT05766735 |
| Routine Care + Glycemic Excursion Minimization (RC+GEM) | Other | Approved | Type 2 Diabetes | RECRUITING | NCT05766735 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Control Group | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Continuous Glucose Monitor | Other | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| DexCom G6 | Other | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| Dexcom Stelo real-time Continuous Glucose Monitor | DEVICE | Preclinical | Gestational Diabetes | NOT_YET_RECRUITING | NCT07356986 |
| Control Group | OTHER | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| REAL-Fam Occupational Therapy Family Coaching | BEHAVIORAL | Approved | Type 1 Diabetes | RECRUITING | NCT07212790 |
| UBLoop System | DEVICE | Approved | Type-1-Diabetes | RECRUITING | NCT07087340 |
| Education, lifestyle counseling, and peer support | BEHAVIORAL | Preclinical | Type 2 Diabetes Mellitus - Poor Control | RECRUITING | NCT07054125 |
| Usual Care Group | OTHER | Approved | Gestational Diabetes Mellitus in Pregnancy | RECRUITING | NCT06957028 |
| Diabetes Treatment | OTHER | Approved | Gestational Diabetes Mellitus in Pregnancy | RECRUITING | NCT06957028 |
| Continuous glucose monitor (CGM) | DEVICE | Approved | Type 2 Diabetes Mellitus (T2DM) | RECRUITING | NCT06939413 |
| Real time continuous glucose monitor (Stelo) | DEVICE | Approved | PreDiabetes | RECRUITING | NCT06841796 |
| real-time continuous glucose monitor | DEVICE | Preclinical | Diabetes Mellitus | COMPLETED | NCT06962735 |
| Dexcom G7 rtCGM | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT06752928 |
| AIDANET+ BPS_RL→AIDANET | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT06728059 |
| Automated Insulin Delivery Adaptive NETwork (AIDANET) | DEVICE | Approved | Type 1 Diabetes | RECRUITING | NCT06728059 |
| Continuous glucose monitoring (CGM) device | DEVICE | Approved | Hypoglycemia, Hyperglycemia | COMPLETED | NCT06645873 |
| Maternal and neonatal outcome data collection for all women in the study | OTHER | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Collection of umbilical cord blood, placental samples and cord tissue in a subset of women (n=25) | OTHER | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Collection of urine, maternal blood at baseline and 28 weeks in a subset of women (n=25) | OTHER | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| continuous blood glucose monitoring in a subset of women (n=25) in the early monitoring group. | DEVICE | Preclinical | Pregnancy Complications | RECRUITING | NCT06545227 |
| Timing of Standardized Meal | BEHAVIORAL | Approved | PreDiabetes | RECRUITING | NCT06507722 |
| CGM device - Insulin group | DEVICE | Preclinical | Gestational Diabetes Mellitus | WITHDRAWN | NCT06490874 |
| CGM device - Metformin group | DEVICE | Preclinical | Gestational Diabetes Mellitus | WITHDRAWN | NCT06490874 |
| Dexcom CGM G6/G6 Pro/G7 | DEVICE | Preclinical | Diabetes | RECRUITING | NCT06483945 |
| Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode | DEVICE | Approved | Continuous Glucose Monitoring | COMPLETED | NCT06338748 |
| SMBG or venous/arterial blood glucose | DEVICE | Approved | Cardiac Disease | RECRUITING | NCT06275971 |
| Placebo | DRUG | Phase PHASE3 | Diabetic Nephropathies | RECRUITING | NCT06217302 |
| Sotagliflozin | DRUG | Phase PHASE3 | Diabetic Nephropathies | RECRUITING | NCT06217302 |
| Blinded Dexcom G7 CGM | DEVICE | Approved | Postpartum Gestational Diabetes Mellitus | TERMINATED | NCT06057805 |
| DEXCOM Continuous Glucose Monitor (CGM) | DEVICE | Approved | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries | ACTIVE_NOT_RECRUITING | NCT06050265 |
| Routine Care (RC) | OTHER | Approved | Type 2 Diabetes | RECRUITING | NCT05766735 |
| Routine Care + Glycemic Excursion Minimization (RC+GEM) | BEHAVIORAL | Approved | Type 2 Diabetes | RECRUITING | NCT05766735 |
| Unified protocol for cognitive behavioral therapy (UP-CBT) | BEHAVIORAL | Approved | Diabetes | RECRUITING | NCT05734313 |
| Dexcom glucose sensor | DEVICE | Approved | Gestational Diabetes | COMPLETED | NCT05714761 |
| Dexcom G6 Pro Continuous Glucose Monitor (CGM) | DEVICE | Preclinical | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05666479 |
| Provider dashboard | DEVICE | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Care team coaching for medical and social needs (HUB) | BEHAVIORAL | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Patient mHealth app linked to a provider dashboard | DEVICE | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| DEXCOM G7 PRO Continuous Glucose Monitor | DEVICE | Approved | Pre-Gestational Diabetes | RECRUITING | NCT05662462 |
| Uncovered CGM during radiologic procedures | OTHER | Approved | Diabetes | COMPLETED | NCT05607576 |
| Continuous glucose monitoring device | DEVICE | Approved | Pregnancy Complications | UNKNOWN | NCT05537480 |
| DexCom G6 continuous glucose monitor | DEVICE | Approved | Type 2 Diabetes | TERMINATED | NCT05504785 |
| Point of care glucose monitoring | DEVICE | Approved | Hyperglycemia | COMPLETED | NCT05442853 |
| Continuous glucose monitoring | DEVICE | Approved | Hyperglycemia | COMPLETED | NCT05442853 |
| DEXCOM G6 CGM | DEVICE | Approved | Diabetic Ketoacidosis | COMPLETED | NCT05439928 |
| SMA visits | BEHAVIORAL | Approved | Type 1 Diabetes | COMPLETED | NCT05431686 |
| Group 2: CGM placement | DEVICE | Approved | Gestational Diabetes | COMPLETED | NCT05430204 |
| Group 1: one-hour GCT | DEVICE | Approved | Gestational Diabetes | COMPLETED | NCT05430204 |
| Participant Finger Stick Glucose Monitoring | OTHER | Approved | Type2Diabetes | COMPLETED | NCT05370612 |
| DexCom G6 | DEVICE | Approved | Type 2 Diabetes | ACTIVE_NOT_RECRUITING | NCT05360056 |
| InControl | DEVICE | Approved | Type 1 Diabetes | TERMINATED | NCT05299177 |
| subcutaneous continuous glucose sensor | DEVICE | Approved | Blood Glucose | COMPLETED | NCT05255783 |
| Afternoon resistance exercise | BEHAVIORAL | Approved | Type 1 Diabetes | COMPLETED | NCT05168488 |
| Fasted morning resistance exercise | BEHAVIORAL | Approved | Type 1 Diabetes | COMPLETED | NCT05168488 |
| real-time CGM | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT05135676 |
| Blinded CGM | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT05135676 |
| Tandem Control IQ Hybrid Closed Loop Insulin Delivery System | DEVICE | Preclinical | Type 1 Diabetes Mellitus | COMPLETED | NCT05059860 |
| Hybrid Closed Loop System | DEVICE | Phase EARLY_PHASE1 | High Risk Acute Lymphoblastic Leukemia | TERMINATED | NCT05006040 |
| Enrollment in existing SDRI diabetes education programs | BEHAVIORAL | Preclinical | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT05000840 |
| Cognitive Behavioral Therapy for Diabetes Distress (CBT-DD) with Continuous Glucose Monitoring | BEHAVIORAL | Approved | Type 1 Diabetes | RECRUITING | NCT05000021 |
| blinded continuous glucose monitor | DEVICE | Approved | Gestational Diabetes Mellitus in Pregnancy | COMPLETED | NCT04948112 |
| real time continuous glucose monitor | DEVICE | Approved | Gestational Diabetes Mellitus in Pregnancy | COMPLETED | NCT04948112 |
| Dexcom G6 CGM with GTS | DEVICE | Approved | Diabetes | COMPLETED | NCT04818242 |
| Continuous glucose monitor | DEVICE | Preclinical | Gestational Diabetes | RECRUITING | NCT06184373 |
| Dexcom Continuous Glucose Monitoring System | DEVICE | Preclinical | Diabetes | COMPLETED | NCT04840446 |
| Dexcom G6 blinded sensor | DEVICE | Approved | Kidney Transplant; Complications | RECRUITING | NCT04783441 |
| occupation-based coaching | BEHAVIORAL | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04753099 |
| Phase 1- Introduction to Dexcom G6 CGM | DEVICE | Approved | Diabetes Mellitus | COMPLETED | NCT04585139 |
| Dexcom G6 continuous glucose monitor | DEVICE | Preclinical | Hyperinsulinism | TERMINATED | NCT06363929 |
| Secure texting | OTHER | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04540536 |
| Dexcom G6 Continuous Glucose Monitor (CGM) System | DEVICE | Preclinical | Diabetes | COMPLETED | NCT04529824 |
| Artificial Pancreas (AP) | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04510506 |
| G6 | DEVICE | Preclinical | Diabetes Mellitus, Type 2 | UNKNOWN | NCT04503239 |
| Dexcom continuous glucose monitor | DEVICE | Approved | Type 2 Diabetes | COMPLETED | NCT05523362 |
| Continuous Glucose Monitoring Device | DEVICE | Approved | Neonatal Hypoglycemia | RECRUITING | NCT04386005 |
| Continuous Glucose Sensor | DEVICE | Preclinical | Diabetes | UNKNOWN | NCT04352907 |
| Cloud-Based Continuous Glucose Monitoring | DEVICE | Approved | Diabetes Mellitus, Type 2 | TERMINATED | NCT04269655 |
| Hyperbaric Oxygen | DEVICE | Approved | Diabetes Mellitus, Type 2 | SUSPENDED | NCT04261738 |
| placebo | DRUG | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| non-HCL | DEVICE | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| verapamil 120mg tablet | DRUG | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| HCL | DEVICE | Phase PHASE3 | Type1 Diabetes | COMPLETED | NCT04233034 |
| Glucose monitoring | DEVICE | Preclinical | Insulin Dependent Diabetes | ACTIVE_NOT_RECRUITING | NCT04225455 |
| Dexcom G6 Continuous Glucose Monitor | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04721145 |
| Multiple Daily Injections | OTHER | Approved | Type 1 Diabetes | WITHDRAWN | NCT04189510 |
| Tandem t:slim X2 with Control-IQ Technology + Dexcom G6 | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT04084171 |
| Self monitoring of blood glucose | DEVICE | Approved | Diabetes Mellitus | RECRUITING | NCT04039763 |
| Dexcom G6 | DEVICE | Approved | Cardiac Disease | RECRUITING | NCT06275971 |
| Tandem t:slim X2 with HCL or PLGS | DEVICE | Phase PHASE4 | Type 1 Diabetes Mellitus | COMPLETED | NCT04016662 |
| self-monitored blood glucose | DEVICE | Approved | Cgm | COMPLETED | NCT03981328 |
| Dexcom G6 Continuous Glucose Monitoring System | DEVICE | Approved | Cgm | COMPLETED | NCT03981328 |
| Standard Bolus Calculator | DEVICE | Approved | Type 1 Diabetes Mellitus | UNKNOWN | NCT03963219 |
| ABC4D | DEVICE | Approved | Type 1 Diabetes Mellitus | UNKNOWN | NCT03963219 |
| Dexcom CGM System | DEVICE | Preclinical | Diabetes Mellitus | UNKNOWN | NCT04905628 |
| DEXCOM G6 RT-CGM | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03805412 |
| SI-Informed Bolus Calculator | OTHER | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03709108 |
| CLC | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03674281 |
| SAP | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03674281 |
| SMBG | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03620357 |
| Blood glucose meter | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03566693 |
| Dexcom G6 CGM System | DEVICE | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03566693 |
| Self-monitoring of blood glucose | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03445377 |
| Real-time continuous glucose monitoring | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT03445377 |
| Dexcom G6 CGM | DEVICE | Approved | Dysglycemia | COMPLETED | NCT05746286 |
| Usual Diabetes Care | OTHER | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03394352 |
| Activity on Board | OTHER | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT03394352 |
| Dexcom CGM unmasked | DEVICE | Approved | Hypoglycemia, Reactive | COMPLETED | NCT03353415 |
| Dexcom CGM masked | DEVICE | Approved | Hypoglycemia, Reactive | COMPLETED | NCT03353415 |
| Continuous Glucose Monitoring (CGM) | DEVICE | Approved | Diabetes | RECRUITING | NCT05734313 |
| Routine Care | OTHER | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03207893 |
| GEM lifestyle modification & continuous glucose monitoring | BEHAVIORAL | Approved | Diabetes Mellitus, Type 2 | COMPLETED | NCT03207893 |
| Acetaminophen Challenge (G6 CGM) | DEVICE | Approved | Diabetes Mellitus | COMPLETED | NCT03087877 |
| Sensor Augmented Therapy | OTHER | Approved | Type1 Diabetes Mellitus | COMPLETED | NCT02985866 |
| Artificial Pancreas | DEVICE | Approved | Type 1 Diabetes | WITHDRAWN | NCT04189510 |
| Point of Care (POC) blood glucose | OTHER | Approved | Diabetes Mellitus | COMPLETED | NCT02904512 |
| Continuous glucose Monitoring (CGM) device and Point of Care (POC) blood glucose | DEVICE | Approved | Diabetes Mellitus | COMPLETED | NCT02904512 |
| Capillary reference (SMBG) | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| Venous reference measurement (YSI) | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| Arterialized-venous reference (YSI) | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02843503 |
| Diabetes Assistant (DiAs) with Closed-Loop | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02750267 |
| Continuous Glucose Monitoring System | DEVICE | Approved | Patients Needing Glucose Control | UNKNOWN | NCT04879693 |
| Sensor Augmented Pump Therapy | OTHER | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT02604524 |
| Closed-Loop Control | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT02604524 |
| Continuous Glucose Monitor (CGM) | OTHER | Approved | Islet Transplantation | COMPLETED | NCT03427931 |
| Dexcom G4 or G5 Platinum CGM system with Share | DEVICE | Approved | Diabetes Mellitus, Type I | COMPLETED | NCT02556554 |
| Dexcom G4 or G5 Platinum CGM system | DEVICE | Approved | Diabetes Mellitus, Type I | COMPLETED | NCT02556554 |
| Dexcom G4 or later generation | DEVICE | Approved | Diabetes Mellitus Type 1 | COMPLETED | NCT02465411 |
| Continuous Glucose Monitor | DEVICE | Approved | Diabetes (DM) | NOT_YET_RECRUITING | NCT07221812 |
| Sensor-Augmented Pump Therapy (SAP) | DEVICE | Approved | Type 1 Diabetes Mellitus | TERMINATED | NCT01939834 |
| Overnight CLC | DEVICE | Approved | Type 1 Diabetes Mellitus | TERMINATED | NCT01939834 |
| RT-CGM | BEHAVIORAL | Approved | Pre-diabetes | COMPLETED | NCT01741467 |
| CGM | DEVICE | Approved | Type1diabetes | UNKNOWN | NCT05663606 |
| Continuous glucose monitoring with DexCom G4 platina | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT02092051 |
| DiAs Control-to-Range System not informed for heart rate | OTHER | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01945060 |
| heart rate Control to Range System (hrCTR) using DiAs Platform | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01945060 |
| Closed Loop with Pramlintide | DEVICE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01839370 |
| Glucose Variability Observation | PROCEDURE | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT01835964 |
| Remote monitoring | DEVICE | Approved | Type 1 Diabetes | COMPLETED | NCT01680653 |
| Mini-glucagon | DRUG | Approved | Type 1 Diabetes | COMPLETED | NCT01680653 |
| Dexcom G4 CGM System | DEVICE | Preclinical | Diabetes Mellitus | COMPLETED | NCT01627184 |
| Heart rate informed SSM+HMM | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01582139 |
| Continuous Glucose Monitoring of glucose levels (Dexcom) | DEVICE | Approved | Diabetes | COMPLETED | NCT01514292 |
| Closed-Loop | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01390259 |
| Open-Loop | DEVICE | Approved | Type 1 Diabetes Mellitus | COMPLETED | NCT01390259 |
| IVBG | DEVICE | Preclinical | Diabetes | COMPLETED | NCT00925080 |
| DexCom™ G4 Continuous Glucose Monitoring System | DEVICE | Approved | Diabetes Mellitus | COMPLETED | NCT01111370 |
| Continuous Glucose Monitoring | OTHER | Approved | Diabetes Mellitus, Type 1 | COMPLETED | NCT04540536 |
| Intravenous Blood Glucose monitoring system | DEVICE | Preclinical | Blood Glucose | COMPLETED | NCT00906490 |
| The Seven Continuous Glucose Monitoring System | DEVICE | Phase PHASE1 | Diabetes, Gestational | COMPLETED | NCT00850135 |
Total products: 364